Cubist Systematic Strategies’s Darling Ingredients DAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$309K Buy
10,000
+1,800
+22% +$60.1K ﹤0.01% 2488
2025
Q2
$311K Hold
8,200
﹤0.01% 2454
2025
Q1
$256K Sell
8,200
-32,100
-80% -$1.12M ﹤0.01% 2436
2024
Q4
$1.36M Sell
40,300
-40,500
-50% -$1.53M 0.01% 1624
2024
Q3
$3M Buy
80,800
+20,300
+34% +$765K 0.02% 1179
2024
Q2
$2.22M Sell
60,500
-78,800
-57% -$3.27M 0.02% 1253
2024
Q1
$6.48M Buy
139,300
+9,800
+8% +$431K 0.04% 796
2023
Q4
$6.45M Buy
129,500
+108,000
+502% +$4.9M 0.04% 711
2023
Q3
$1.12M Buy
21,500
+6,100
+40% +$381K 0.01% 1799
2023
Q2
$982K Buy
15,400
+11,100
+258% +$676K 0.01% 1972
2023
Q1
$251K Buy
+4,300
New +$270K ﹤0.01% 3091
2022
Q4
Sell
-8,100
Closed -$536K 4310
2022
Q3
$536K Buy
+8,100
New +$565K ﹤0.01% 3110

Other funds holding DAR

Cubist Systematic Strategies's DAR Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Darling Ingredients (DAR) stake by 100% in Q3 2025, selling an estimated $9.2M and leaving 1,100 shares worth $34K. The position accounts for ﹤0.01% of the portfolio, ranked #2876.

Cubist Systematic Strategies first reported a position in DAR in Q2 2014 and has held it in 40 quarters since. The position peaked at $27M in Q2 2022. 468 funds tracked by Wall St. Rank hold DAR as of Q3 2025.

  • Cubist Systematic Strategies held 1,100 shares of Darling Ingredients worth $34K as of Q3 2025.
  • Cubist Systematic Strategies sold 275,409 Darling Ingredients shares in Q3 2025, an estimated $9.2M.
  • Darling Ingredients made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2876 holding.
  • Cubist Systematic Strategies first reported a position in Darling Ingredients in Q2 2014 and has held it in 40 quarters since.
  • Cubist Systematic Strategies's Darling Ingredients position peaked at $27M in Q2 2022.
  • 468 funds tracked by Wall St. Rank held Darling Ingredients as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.